Factrack Inc., a biotech firm, is expected to grow rapidly in the next three years and then have a level growth rate for the foreseeable future. The firm expects free cash flows of $342.5 million, $512.3 million, and $750 million over the next three years, and thereafter its cash flows will grow at a steady rate of 8 percent per year. The company has no nonoperating assets (NOA) . If the appropriate WACC is 11.25 percent, what is the enterprise value of this business? (Round to the nearest million.)
A) $19,367 million
B) $18,101 million
C) $26,190 million
D) $24,923 million
Correct Answer:
Verified
Q73: You are interested in investing in a
Q74: Simpltar Co. is expected to grow rapidly
Q75: Atamony makes circuit boards and markets them
Q76: Settetocol, Inc., has cash of $12,000, receivables
Q77: You are using the FCFF approach to
Q79: Symbyrec Phonic, an electronics manufacturer, is expected
Q80: Cervil had an EBIT of $247 million
Q81: Explain how valuations can differ between public
Q82: What difficulties are associated with valuing real
Q83: Alfred Sautin wants to invest in Dieciring,
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents